University of Hong Kong and Sinopharm test city’s first Omicron-targeting vaccine. Photo: Edmond So
University of Hong Kong and Sinopharm test city’s first Omicron-targeting vaccine. Photo: Edmond So

University of Hong Kong, Sinopharm launch city’s first trial for Omicron-targeting vaccine which could be ready in November

  • Some 500 Hongkongers have been recruited for clinical trial, out of which 100 have already received the new jabs
  • Lead researcher Professor Ivan Hung says new vaccine could achieve a 60 to 70 per cent overall protection rate

University of Hong Kong and Sinopharm test city’s first Omicron-targeting vaccine. Photo: Edmond So
University of Hong Kong and Sinopharm test city’s first Omicron-targeting vaccine. Photo: Edmond So
READ FULL ARTICLE